RNA-seq paired-end libraries with the Illumina TruSeq Stranded Total RNA kit. 173 Ribosomal RNA was removed with the Ribo-Zero Human/Mouse/Rat kit. 174 Libraries were multiplexed and sequenced on an Illumina HiSeq 2500 instrument 175 for 101 cycles. 176 Bioinformatics 177 Whole exome sequence data was analyzed in house 43 and whole genome data 178 was analyzed in collaboration with the Broad Institute of MIT and Harvard using 179 methodology described previously 20 . Briefly, BWA was used for alignment.
180
GATK was used for single nucleotide polymorphism and insertion/deletion calls. 181 Additional variant annotation was performed using the Variant Effect Predictor 182 (VEP) 45 . Variants of interest were limited to polymorphisms with less than 0.005 183 allelic frequency in the gnomAD and ExAC databases 8, 9 . Whole genome copy 184 number analysis, with consideration of structural changes, was done using 185 Genome STRiP 2.0 46 . 186 For analyses of RNA-seq data, read quality was assessed with FastQC v0.11.3 187 (Babraham Bioinformatics, Cambridge, UK) and MultiQC v1.2 47 . Reads were 188 aligned to the human genome version GRCh37 by the STAR v2.5.3a 48 aligner in 189 two-pass mode within the sample and across replicates for each sample sets. 190 Annotations were derived from the Human GENCODE v19 (Ensemble74). 191 FeatureCount v1.5.2 49 from the Subread package, was used to generate gene 192 expression matrix with the following non-default settings, reads must be paired, 193 both the pairs must be mapped, use only uniquely mapped reads, multi-mapped 194 reads are not counted, chimeric reads are not counted and strand specificity 195 10 turned on. Anaquin 50 was further used to evaluate alignment sensitivity and gene 196 expression. Here sensitivity indicates the fraction of annotated regions covered 197 by alignments of the reads by STAR (Table S2 ). No limit of quantification or limit 198 of detection was reported. 199 For discovery of novel or known alternative splicing events we used a 200 combination of CASH v2.2.1 51 and MAJIQ v1.1.3a 52 . CASH was operated with 201 default settings. MAJIQ was run with a minimum of 5 reads for junction detection 202 and 10 reads for the calculation of delta percent spliced-in (dPSI). EdgeR 203 (v3.2.2) 53 was used to perform differential gene expression with default settings. 204 Data normalization was performed using trimmed mean of M-values (TMM).
205
Next, the raw read counts were converted to transcript per million ( Moreover, the 1.75e -3 gnomAD allele frequency of the p.Thr383IlefsTer13 variant 266 is higher than expected for recessive pathogenic variants and two homozygous 267 individuals are reported in the gnomAD database. Since it has been proposed 268 that up to 1 in 4-5 individuals in the general population may be a carrier of null 269 mutations in IRD genes 71 it was possible that the presence of variant 270 p.Thr383IlefsTer13 was an incidental finding. 271 We therefore decided to test for two possible disease scenarios. One is that 272 CNGB3 accounts for the cone dysfunction syndrome and the second allele is a 273 non-coding variant. In this case the Chiari malformation has a separate, In order to evaluate if day 160 ROs can be used as informative surrogates for the 300 adult human retinal transcriptome, we examined the expression levels of 270 301 known IRD genes reported in the RetNet database. For this analysis, we 302 compared an in-house dataset composed of 3 post-mortem human normal 303 retinas (HNR, N=3) 56 to ROs derived from the unaffected sibling (N=5) or skin or 304 whole blood samples taken from the GTEx database ( Figure 3 and Table S4 ) 21 . 305 Skin and blood represent tissues that are more readily availableand thus 306 commonly usedfor surrogate diagnostic testing. We found 224 IRD genes to 307 be expressed in HNR (TPM>1). Interestingly we were able to detect expression 308 of 254 IRD disease genes in the RO samples ( Figure 3 Table S4 ). Since IRD genes were very 316 poorly represented in the blood samples, we excluded blood from further 317 analysis. 318 We next examined the complexity of the HNR, RO and skin transcriptomes, ROs are composed of a more diverse cell population than skin. More importantly, 331 in IRD genes, the gap in complexity between the HNR (946 junctions) and ROs 332 (739 (78%)) as compared to skin (227(24%)) is even greater (Figure 3d & Table   333 S5). Thus, the RO transcriptome provided a close facsimile of the human retinal 334 and IRD transcriptomes at the gene expression and splicing pattern levels, 335 whereas the skin transcriptome did not.
336

Detection of a novel non-coding pathogenic variant in CNGB3 337
In order to find the underlying genetic cause of the retinal degeneration in OGI-338 081 affected patients, we conducted differential splicing and gene expression 339 analyses of the RNA-seq data obtained from day 160 ROs of affected versus 340 unaffected siblings. The differential splicing analysis was conducted with CASH 341 51 and MAJIQ 52 algorithms, and we used edgeR algorithm 53 for differential gene 342 expression. CASH detected 106 differential splicing events in 101 genes (Table   343 S6), while MAJIQ detected 522 differential splicing junctions in 260 genes (Table   344 S7). A comparison to the 642 genes with DNA variant pairs indicated that only 345 two genes, CNGB3 and NCALD, had altered splicing patterns and a DNA variant 346 in each of their alleles that segregated according to disease status in OGI-081 347 (Figure 4a ).
348
For the NCALD gene, the alternative splicing events identified by CASH and 349 MAJIQ were isoform switching events between minor isoforms (data not shown) Table S8 ). Given such large distances, it is not likely that these variants 353 could cause the alternative splicing events. Moreover, the differential gene 354 expression analysis did not find the NCALD gene to be differentially expressed 355 between the affected and unaffected siblings (Table S9 ). Taken together, these 356 results indicate that the NCALD gene variants are most likely not the genetic 357 cause for the disease phenotypes observed in OGI-081. 358 We next examined the CNGB3 gene locus. Based on segregation in the family, (Figure 5a&b ). The cryptic exon is spliced between canonical exon 14 and 369 exon 15 and will therefore be termed exon14b from hereon. The inclusion of 370 exon 14b was validated by RT-PCR and subsequent cloning and Sanger 371 sequencing of the novel longer isoform from the two affected siblings (Figure 5b) . (Table S9) ). These two frame shift alleles are predicted to 384 encode truncated proteins. The protein encoded by the exon 14b including 385 isoform is predicted to maintaining a full transmembrane domain but lack the 386 ligand binding domain of CNGB3 (Figure 5c ). Similarly, the protein encoded by 387 the isoform carrying the known pathogenic variant c.1148delC; 388 p.Thr383IlefsTer13 is predicted to have a truncated transmembrane domain in 389 addition to lacking the ligand binding domain (Figure 5c ). In order to determine 390 whether the truncated CNGB3 proteins are being translated, we performed 391 immunohistochemistry on ROs from the exon 14b allele carrier parent (OGI-081-392 200) and one affected sibling (OGI-081-197, Figure 6 ). CNGB3 is a subunit of the 393 cone cyclic nucleotide-gated (CNG) channel, which localizes to cone 394 photoreceptor outer segments in chicken and mice 76, 77 . We have also validated 395 the localization of human CNGB3 to cone photoreceptor outer segments in the 396 human retina ( Figure S2 ). We therefore immunostained ROs for CNGB3 and ML 397 opsin, the latter serving as a marker for photoreceptor outer segments. For these 398 studies, stage 3 ROs were kept in culture for a total of 262 days, allowing cones 399 full opportunity to mature and localize ML opsin and CNGB3 to the photoreceptor 400 outer segments. As expected, CNGB3 co-localized with ML opsin in cone 401 photoreceptor outer segments in the parent (Figure 6c With the identification of the non-coding pathogenic variant in CNGB3, we set out 415 to examine the mechanism by which it promotes the inclusion of exon 14b. We and NNSPLICE 80 . All three algorithms predicted chr8:g.87618576G>A to 420 strengthen a cryptic donor splice site (DSS) ( Table 2) . All three algorithms also 421 detected a potential acceptor splice site (ASS) at position c.1663-2238, exactly 422 where our Sanger sequencing indicated the acceptor site of exon 14b resides.
423
Interestingly, exon 14b ASS is a stronger than the one located at exon 15 (Table   424 2). It is plausible that the availability of this acceptor site and its ability to compete Next, using OGI-081 as a true positive case, we tested whether splicing 432 prediction algorithms could be used to prioritize candidate non-coding splicing 433 altering variants, circumventing the need for RNA-seq analysis. We annotated 434 the 3,268 rare variants with allelic pairs identified in OGI-081 with two splicing 435 prediction programs. (i). Alamut Batch that makes its prediction by the combined 436 calculations of the same splicing predictions algorithms as Alamut visual but is 437 capable of calculating the effects of multiple variants. (ii). SpliceAI, a deep neural 438 network tool, to predict splice junctions from pre-mRNA transcript sequence 18 .
439
Alamut batch calculated a high probability for altering splicing for 532 variants in 440 315 genes (Table S10 ). Although variant chr8:g.87618576G>A, the novel 441 pathogenic variant identified in this study, was predicted by Alamut Batch to 442 strongly activate a cryptic donor site the large number of additional candidate 443 variants make this tool too cumbersome for identification of candidate non-coding 444 pathogenic variants. For SpliceAI, to identify synonymous exonic, near intronic, 445 and deep intronic variants predicted to affect splicing at a validation rate of 40% 446 the authors used  Score greater than or equal to 0.2, 0.2, and 0.5 respectively.
447
Out of the variants segregating in OGI-081only eight had scores 0.2<0.5 and only 448 one, variant Chr9:g.86536129C>T, received a  Score >0.5 (Table S11 ). Variant 47, 48, 82, [49] [50] [51] [52] [53] [54] [55] 81 . Ex vivo organoid models are being developed for a 472 multitude of tissues including brain 83,84 , kidney 85 , liver 86,87 and lung 88 .
473
Non-coding variants present a challenge for a correct genetic diagnosis that is 474 imperative for a successful genetic therapy. The combination of WGS and RNA-475 seq methodologies allows us to both detect non-coding variants and evaluate 476 their functionality throughout the genome. Indeed, a similar approach has already 477 been successfully employed to diagnose diseases where RNA could be 478 harvested from biopsies of disease-relevant tissue 19, 20 . These studies relied on 479 the availability of large control datasets of RNA-seq samples from unaffected 480 individuals and/or a large cohort of patients 19, 20 . Our work shows that the correct 481 diagnosis of non-coding variants is possible without reliance on such resources.
482
WGS analysis of all five members of OGI-081 and segregation analysis of the 483 variants within the family narrowed down the search from tens of thousands of 484 variants to a few hundred with allelic pairs. We then used RNA-seq analysis 485 comparing two affected siblings to an unaffected one as an orthogonal approach filters to identify candidate pathogenic variants for "gene by gene" validation 504 methods, circumventing the need for RNA-seq analysis of ROs. We found that 505 the more established approach represented by the Alamut Batch method of 506 combining the calculations of several splicing predictors that are designed to 507 identify known splicing motifs yielded too many candidates for gene by gene 508 validation. In contrast, the more recent approach of deep neuronal networks As mentioned above, differential gene expression analysis was less informative 519 in the OGI-081 datasets. We compared gene expression levels from each of the 520 affected siblings to that of the unaffected sibling (Table S9) . We found 401 genes 521 to be consistently down regulated, of which 27 were Y linked as expected given 522 that the two affected siblings are females while the unaffected sibling is a male.
523
We excluded these Y linked genes from further analysis. Tools are not currently 524 available to filter out non-Y linked genes that may be differentially expressed 525 25 between the sexes under normal conditions in ROs. Of the remaining 374 down 526 regulated genes, 29 also contained allelic variant pairs (Table S3 ). In addition, 527 we found 1120 genes to be consistently up regulated between the two affected 528 siblings and the unaffected sibling (Table S9 ). Of the up regulated genes, 15 also 529 contained allelic variant pairs (Table S3 ). None of the 44 differentially expressed 
